mortality/aging
• increased incidence of death due to ruptured abdominal aorta aneurysyms following angiotensin-II infusion compared to mutant mice wild-type for Cxcl10
|
cardiovascular system
• decrease in lesion size in the angiotensin-II induced model compared to mutant mice wild-type for Cxcl10
|
• display more severe morphological changes following angiotensin-II infusion compared to mutant mice wild-type for Cxcl10
|
• increase in the suprarenal aortic diameter and suprarenal/thoracic to infrarenal aortic area ratios in mice infused with angiotensin-II compared to mutant mice wild-type for Cxcl10
|
• large aortic aneurysms with spiral dissections are seen following angiotensin-II infusion
• decrease in CD4+ T cell accumulation in angiotensin-II induced aneurysms
|
• seen following angiotensin-II infusion
|
• increased incidence of death due to ruptured abdominal aorta aneurysyms following angiotensin-II infusion compared to mutant mice wild-type for Cxcl10
• large aortic aneurysms with spiral dissections are seen following angiotensin-II infusion
• increase in the incidence of grade III aneurysms following angiotensin-II infusion compared to mutant mice wild-type for Cxcl10
|
immune system
• decrease in macrophage accumulation in the arterial wall in angiotensin-II treated mice
|
• decrease in CD4+ T cell accumulation in angiotensin-II induced aneurysms
|
hematopoietic system
• decrease in macrophage accumulation in the arterial wall in angiotensin-II treated mice
|
• decrease in CD4+ T cell accumulation in angiotensin-II induced aneurysms
|
cellular
• decrease in macrophage accumulation in the arterial wall in angiotensin-II treated mice
|